Advocates disappointed by VOICE development
The announcement today that one arm of a large-scale HIV prevention trial known as VOICE will stop early is disappointing, but must be seen in context, according to the global advocacy organization AVAC.
News
Read More » Advocates disappointed by VOICE development
Prep: VOICE study ‘modified’
A large-scale clinical trial evaluating whether daily use of an oral tenofovir or vaginal gel containing antiretroviral drugs can prevent HIV infection in women is being modified because an interim review found that the study cannot show that the oral tenofovir is effective. Read the full statement here.
AIDS a model for chronic diseases
HIV/AIDS care has created an effective chronic care model that could be used to improve care for non-communicable diseases such as diabetes, cancer and obesity.
Health sector to stand against rape
HIV/AIDS care has created an effective chronic care model that could be used to improve care for non-communicable diseases such as diabetes, cancer and obesity.
AIDS vaccine critical
BANGKOK '€“ Humans are not good at changing our sexual behaviour, which is why thousands of people who know they should use condoms are still getting HIV.
Two clues revealed about how Thai vaccine worked
BANGKOK - Two years ago, an alliance of Thai and US scientists revealed that a huge trial of an AIDS vaccine had for the first time protected some people from HIV '€“ but they didn'€™t know why or how it had worked.
Hearing loss can affect anyone
Hearing loss can strike people of any age. In fact, research shows that 8 out of every 100 people with hearing loss are under the age of 18.
Early ARV treatment will save lives
Government's decision to offer free ARV treatment to people with CD4 counts of 350 or less has been welcomed as a life-saver.
Addressing adult TB can reduce number of children with tuberculosis Living with AIDS # 480
Improved and sustained efforts to diagnose and treat TB need to be made to address tuberculosis infection among children. This is according to the National Institute for Communicable Diseases (NICD), after results of a clinical study it conducted showed that prophylaxis with Isoniazid does not prevent TB in children.
PEP services not up to scratch Living with AIDS # 477
A study examining the quality of post-exposure prophylaxis (PEP) services for survivors of rape in Limpopo and the North West has shown a lack of trained health care workers that provide the service.
More tests on encouraging microbicide Living with AIDS # 476
A large follow-up clinical trial to confirm the encouraging result last year of a small study that tested an antiretroviral-based microbicide gel which showed that it could reduce HIV infection in women by almost 40%, is due to begin in a few weeks.
Tara Klamp not to used outside KZN
The government will not be using the controversial Tara Klamp device to circumcise men outside of KwaZulu-Natal, according to health Deputy Director General Dr Yogan Pillay.
New policy saves thousands of babies from HIV
Government has slashed the HIV transmission rate from pregnant mothers to their babies to merely 3.5 percent, potentially sparing some 67 000 babies from HIV infection.
Eight out of 10 ARV patients alive 5 years later
DURBAN - Despite under-reporting of deaths more than 80% of patients on antiretrovirals (ARVs) in South Africa are still alive five years into their treatment programme.
What works
DURBAN - South Africa is making real progress in shifting HIV treatment delivery to lower levels of health workers, enabling more patients to be reached.